Hanna Algattas, MD, joined the University of Pittsburgh Department of Neurological Surgery residency program in June of 2016 after graduating from the University of Rochester School of Medicine. He previously graduated from summa cum laude from Colgate University with a degree in cellular neuroscience with high honors.
Prior to matriculation to medical school, Dr. Algattas worked with animal models of Alzheimer’s disease at the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Algattas has been involved in research regarding traumatic brain injury (TBI) pathophysiology and management, Chronic Traumatic Encephalopathy (CTE), endoscopic endonasal approaches to craniopharyngiomas, cost-effectiveness in neuro-oncology, and outcome improvement after cranial and spinal surgery. He currently is involved in research regarding outcomes in skull base and endonasal neurosurgery as well as traumatic brain injury.
Dr. Algattas was born and raised in Syracuse, N.Y. Interests outside neurosurgery include weightlifting, squash, professional sports, and crossword puzzles.
Specialized Areas of Interest
Professional Organization Membership
Education & Training
- BA, Cellular Neuroscience, Colgate University, 2012
- MD, University of Rochester Medical School, 2016
Honors & Awards
- Joseph C. Maroon Aequanimitas Award, 2021
- Neuroscience Research Foundation/Heindl Foundation Research Grant, NRF, 2020
- Young Neurosurgeons Forum Oral Presentation, AANS, 2015
- Office of Medical Education Research Award, University of Rochester SOM, 2013
- James M. Maury MD Endowed Scholarship, Colgate University, 2012
- Elias J. Audi Scholarship, Colgate University, 2012
- Charles A. Dana Scholar, Colgate University, 2012
- Dr. Leo Speno Health Sciences Prize, Colgate University, 2012
- William K. Edmonton Neuroscience Award, Colgate University, 2012
Dr. Algattas’ recent research interests and projects include evaluating the role for the endoscopic endonasal approach in resection of craniopharyngiomas with intraventricular extension and two IRB-based protocols. His IRB study focuses on evaluating the role of a heart rate variability monitor (i.e. Apollo Biostrap) on performance and stress management of neurosurgery residents and the second evaluates the impact of COVID-19 sanctioned restrictions on the neurotrauma presentations in the Pittsburgh metropolitan area and the impact on health care delivery.